Drugs / AKR-963
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01229566 | Oct 2010 → Jul 2012 | — | Trygg Pharma, Inc. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AKR-963 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01229566 ↗ |